Palisade Bio Inc.

NASDAQ: PALI · Real-Time Price · USD
0.81
-0.00 (-0.61%)
At close: Aug 15, 2025, 3:58 PM
0.80
-1.45%
After-hours: Aug 15, 2025, 06:16 PM EDT

Palisade Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 4K n/a n/a n/a -250K n/a n/a 250K n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1K 1K 2K 1K 1K 1K 54K 1K 27K 26K 26K 46K 49K 46K 44K 42K n/a 9.03K
Gross Profit
-1K -1K 2K -1K -1K -1K -304K -1K -27K 224K -26K n/a -49K -46K -44K -42K n/a -9.03K
Operating Income
-2.84M -2.31M -3.38M -3.59M -4.21M -3.67M -3.15M -3.78M -3.61M -2.53M -3.85M -4.41M -3.57M -3.89M -4.03M -3.02M -32.86M -1.95M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.92K
Pretax Income
-2.78M -2.23M -3.34M -3.49M -4.08M -3.53M -2.97M -3.6M -3.39M -2.34M -3.72M -3.99M -2.34M -4.21M 1.07M 8.09M -31.75M -2.29M
Net Income
-2.78M -2.23M -3.34M -3.49M -4.08M -3.53M -2.97M -3.6M -3.39M -2.34M -3.72M -3.99M -2.34M -4.21M 1.07M 8.09M -31.75M -4.03M
Selling & General & Admin
1.17M 1.36M 1.3M 1.46M 1.58M 1.46M 1.56M 1.67M 1.43M 1.54M 1.5M 2.08M 2.25M 2.93M 3.23M 2.39M 2.43M 1.26M
Research & Development
1.68M 950K 2.08M 2.14M 2.63M 2.21M 1.73M 1.74M 2.18M 1.24M 2.34M 1.93M 1.32M 959K 800K 624K 314K 692K
Other Expenses
n/a n/a n/a n/a n/a n/a 187K 362K n/a n/a n/a 410K 8K 1K 11K 38K 30.12M n/a
Operating Expenses
2.84M 2.31M 3.38M 3.59M 4.21M 3.67M 3.29M 3.78M 3.61M 2.78M 3.85M 4.41M 3.57M 3.89M 4.03M 3.02M 32.86M 1.95M
Interest Expense
2K 1K 3K 6K 2K 1K 4K 8K 3K 189K 3K 4K 5K 1K 5K 26K 655K 1.71M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.84M 2.31M 3.38M 3.59M 4.21M 3.67M 3.29M 3.78M 3.61M 2.78M 3.85M 4.41M 3.57M 3.89M 4.03M 3.02M 32.86M 1.95M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a -1K n/a n/a n/a n/a n/a n/a n/a 26K n/a 1.71M
Shares Outstanding (Basic)
4.8M 4.8M 5.82M 5.82M 5.82M 768.14K 5.82M 489.62K 6.4M 4.32M 1.8M 64.95K 405.9K 324.45K 270.66K 16.13K 152.43K 832.35K
Shares Outstanding (Diluted)
4.8M 4.8M 8.54M 5.82M 5.82M 12.63M 9.27M 489.62K 427.86K 287.7K 1.8M 64.95K 405.9K 324.48K 270.66K 242.13K 176.63K 237.39K
EPS (Basic)
-0.58 -0.46 -0.57 -2.32 -3.32 -4.59 -0.51 -7.38 -7.93 -8.13 -1.49 -61.5 -86.55 -194.4 3.96 315.00 -208.27 -4.84
EPS (Diluted)
-0.58 -0.46 -0.39 -2.32 -3.32 -4.59 -0.32 -7.38 -7.93 -8.13 -1.49 -61.5 -2.75 -13.94 3.96 33.40 -179.74 -16.98
EBITDA
-2.78M -2.23M -3.34M -3.48M -4.08M -3.52M -2.97M -3.59M -3.39M -2.31M -3.71M -3.99M -2.29M -4.16M 1.12M 8.11M -31.09M -2.32M
EBIT
-2.78M -2.23M -3.34M -3.48M -4.08M -3.53M -2.97M -3.59M -3.39M -2.34M -3.72M -3.99M -2.34M -4.2M 1.08M 8.11M -31.09M -2.28M
Depreciation & Amortization
1K 1K -3K 1K 1K 1K 43.81K 1K 27K 26K 26K 46K 49K 46K 44K 42K 1K 1K